CONCORD BIOTECH
Back to Income Statement
|
CONCORD BIOTECH Last 5 Year Consolidated Net Profit History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Consolidated Net Profit | ₹308 Cr | ₹240 Cr | ₹17 Cr | ₹235 Cr | ₹1,690 Cr |
What is the latest Consolidated Net Profit of CONCORD BIOTECH ?
Year | Consolidated Net Profit |
---|---|
Mar2025 | ₹308 Cr |
Mar2024 | ₹240 Cr |
Mar2023 | ₹17 Cr |
Mar2022 | ₹235 Cr |
Mar2021 | ₹1,690 Cr |
How is Consolidated Net Profit of CONCORD BIOTECH Trending?
Years | Consolidated Net Profit | % Change | |
---|---|---|---|
Mar2025 | ₹308 Cr | 28.33 | |
Mar2024 | ₹240 Cr | 1,272.47 | |
Mar2023 | ₹17 Cr | -92.55 | |
Mar2022 | ₹235 Cr | -86.10 | |
Mar2021 | ₹1,690 Cr | - |
Compare Consolidated Net Profit of peers of CONCORD BIOTECH
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
CONCORD BIOTECH | ₹17,126.7 Cr | 2.3% | -10.9% | 5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹394,115.0 Cr | 3.5% | -3.4% | -5.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,735.0 Cr | 3.7% | -10.2% | 25.6% | Stock Analytics | |
CIPLA | ₹126,313.0 Cr | 5.3% | 6.1% | -1.3% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,592.0 Cr | 1.4% | 4.6% | 7.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,095.0 Cr | 3.9% | 0% | -9.9% | Stock Analytics |
CONCORD BIOTECH Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
CONCORD BIOTECH | 2.3% |
-10.9% |
5% |
SENSEX | -0% |
-2.4% |
1.2% |
You may also like the below Video Courses